Quince Therapeutics, Inc.(QNCX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

QNCX Quince Therapeutics, Inc.

盘后交易 02-10 17:32:30 EST

0.5277

+0.3977

+305.92%

盘后0.7090

+0.1813+34.36%

17:32 EST

最高0.6520	最低0.2459	成交量15.18亿
今开0.2834	昨收0.1300	日振幅312.38%
总市值2,938万	流通市值2,615万	总股本5,568万
成交额5.54亿	换手率3,063.77%	流通股本4,956万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"QNCX","market":"US","secType":"STK","nameCN":"Quince Therapeutics, Inc.","latestPrice":0.5277,"timestamp":1770757200000,"preClose":0.13,"halted":0,"volume":1518342168,"hourTrading":{"tag":"盘后","latestPrice":0.709,"preClose":0.5277,"latestTime":"17:32 EST","volume":26245797,"amount":14281221.58122702,"timestamp":1770762749712,"change":0.1813,"changeRate":0.343566,"amplitude":0.564336},"delay":0,"changeRate":3.0592307692307688,"floatShares":49558000,"shares":55681490,"eps":-1.209231,"marketStatus":"盘后交易","change":0.3977,"latestTime":"02-10 17:32:30 EST","open":0.2834,"high":0.65199,"low":0.2459,"amount":554379476.1773638,"amplitude":3.123769,"askPrice":0.7101,"askSize":100,"bidPrice":0.7071,"bidSize":259,"shortable":0,"etf":0,"ttmEps":-1.209231,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770771600000},"marketStatusCode":4,"adr":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":0.13,"preHourTrading":{"tag":"盘前","latestPrice":0.28,"preClose":0.13,"latestTime":"09:29 EST","volume":67510403,"amount":15814401.01648196,"timestamp":1770733799775,"change":0.15,"changeRate":1.153846,"amplitude":0.744615},"postHourTrading":{"tag":"盘后","latestPrice":0.709,"preClose":0.5277,"latestTime":"17:32 EST","volume":26245797,"amount":14281221.58122702,"timestamp":1770762749712,"change":0.1813,"changeRate":0.343566,"amplitude":0.564336},"volumeRatio":124.9495,"impliedVol":3.9057,"impliedVolPercentile":0.9721},"requestUrl":"/m/hq/s/QNCX","defaultTab":"news","newsList":[{"id":"1199797671","title":"Quince Therapeutics任命Lifesci Capital为独家财务顾问，探索战略转型方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1199797671","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199797671?lang=zh_cn&edition=full","pubTime":"2026-02-10 05:06","pubTimestamp":1770671179,"startTime":"0","endTime":"0","summary":"生物制药企业Quince Therapeutics, Inc.近日宣布，已正式聘请Lifesci Capital担任其独家财务顾问。双方将携手评估包括资本重组、业务合作及潜在交易在内的多项战略发展路径。\n此次合作旨在通过专业财务机构的深度参与，全面优化公司战略布局。Lifesci Capital将凭借其在生命科学领域的丰富经验，为Quince Therapeutics提供定制化解决方案，助力企业实现长期价值提升。\n该决策反映出公司积极应对市场变化的战略主动性。通过系统化评估各类发展方案，Quince Therapeutics有望在快速演变的行业环境中抢占先机，为股东创造可持续回报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNCX"],"gpt_icon":0},{"id":"1155581659","title":"Quince Therapeutics公布共济失调-毛细血管扩张症Edsp关键三期NEAT临床试验主要结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1155581659","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155581659?lang=zh_cn&edition=full","pubTime":"2026-01-30 04:10","pubTimestamp":1769717410,"startTime":"0","endTime":"0","summary":"Quince Therapeutics, Inc. 近日披露了其针对共济失调-毛细血管扩张症（Ataxia-Telangiectasia）研发药物Edsp的关键性三期NEAT临床试验的初步结果。此次公布的数据标志着该疗法在临床开发进程中的重要节点，为后续评估提供了关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNCX"],"gpt_icon":0},{"id":"2594294036","title":"Quince Therapeutics, Inc.盘中异动 早盘股价大跌5.05%报3.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594294036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594294036?lang=zh_cn&edition=full","pubTime":"2025-12-26 22:52","pubTimestamp":1766760723,"startTime":"0","endTime":"0","summary":"北京时间2025年12月26日22时52分，Quince Therapeutics, Inc.股票出现异动，股价急速跳水5.05%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的精准治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226225204a6d31f8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226225204a6d31f8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4539","BK4139","QNCX"],"gpt_icon":0},{"id":"1170039743","title":"Quince Therapeutics宣布在共济失调-毛细血管扩张症患者的三期Neat临床试验中完成最后一位患者的最后一次随访","url":"https://stock-news.laohu8.com/highlight/detail?id=1170039743","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170039743?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:01","pubTimestamp":1765803694,"startTime":"0","endTime":"0","summary":"Quince Therapeutics宣布在共济失调-毛细血管扩张症患者的三期Neat临床试验中完成最后一位患者的最后一次随访","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNCX","BK4139"],"gpt_icon":0},{"id":"2518202735","title":"Quince Therapeutics, Inc.盘中异动 大幅跳水5.30%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518202735?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:18","pubTimestamp":1741634284,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时18分，Quince Therapeutics, Inc.股票出现波动，股价大幅下跌5.30%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6316.63%、3862.24%、1024.29%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031804abf37cc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031804abf37cc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QNCX","LENZ"],"gpt_icon":0},{"id":"2512370483","title":"Quince Therapeutics, Inc.盘中异动 急速上涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512370483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512370483?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:31","pubTimestamp":1739975484,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分，Quince Therapeutics, Inc.股票出现波动，股价大幅拉升5.67%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Osr Holdings, Inc.、Allogene Therapeutics, Inc.、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为204.04%、202.00%、65.54%，振幅较大的相关个股有Allogene Therapeutics, Inc.、Azitra Inc、Osr Holdings, Inc.，振幅分别为31.34%、11.29%、10.29%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223124a24bf93b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223124a24bf93b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QNCX","LENZ"],"gpt_icon":0},{"id":"2512660351","title":"Quince Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512660351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512660351?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889060,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Quince Therapeutics, Inc.股票出现异动，股价大幅上涨5.00%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为275.19%、90.58%、58.67%，振幅较大的相关个股有Allakos Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为6.84%、6.43%、6.13%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231009889fc5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231009889fc5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","QNCX"],"gpt_icon":0},{"id":"2511575105","title":"Quince Therapeutics, Inc.盘中异动 下午盘快速上涨5.00%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511575105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511575105?lang=zh_cn&edition=full","pubTime":"2025-02-14 02:14","pubTimestamp":1739470443,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日02时14分，Quince Therapeutics, Inc.股票出现异动，股价快速上涨5.00%。截至发稿，该股报1.47美元/股，成交量9.5076万股，换手率0.22%，振幅6.67%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214021403abcddd8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214021403abcddd8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QNCX","LENZ"],"gpt_icon":0},{"id":"2510986161","title":"Quince Therapeutics, Inc.盘中异动 早盘快速跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510986161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510986161?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:28","pubTimestamp":1739201329,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时28分，Quince Therapeutics, Inc.股票出现波动，股价快速跳水5.41%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2546.55%、1506.14%、953.59%，振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Immatics N V C/Wts 01/07/2025 ，振幅分别为69.83%、66.09%、50.50%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023284998808456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023284998808456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","BK4139","LENZ"],"gpt_icon":0},{"id":"2509676407","title":"D. Boral Capital：维持Quince Therapeutics(QNCX.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509676407","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509676407?lang=zh_cn&edition=full","pubTime":"2025-02-05 20:11","pubTimestamp":1738757515,"startTime":"0","endTime":"0","summary":"D. Boral Capital：维持Quince Therapeutics(QNCX.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/05201147968474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","QNCX"],"gpt_icon":0},{"id":"2505971271","title":"Quince Therapeutics, Inc.股价重挫14.46% 市值跌192.58万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505971271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505971271?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:32","pubTimestamp":1737469934,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时32分，Quince Therapeutics, Inc.股票出现异动，股价快速下挫14.46%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Dogwood Therapeutics, Inc.、Replimune Group, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Dermata Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为530.12%、161.41%、28.48%，振幅较大的相关个股有Allakos Inc.、Cellectis Ads Each Repr 1 Ord Spon、Equillium, Inc.，振幅分别为111.05%、107.43%、107.00%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223214986e32ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223214986e32ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","QNCX","BK4139"],"gpt_icon":0},{"id":"2492181805","title":"Quince Therapeutics, Inc.盘中异动 股价大涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492181805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492181805?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:32","pubTimestamp":1734532361,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时32分，Quince Therapeutics, Inc.股票出现波动，股价大幅拉升5.71%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Cognition Therapeutics, Inc.、Polyrizon Ltd.、Tc Biopharm  Plc涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1008.78%、299.12%、240.76%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cognition Therapeutics, Inc.、Polyrizon Ltd.，振幅分别为66.83%、37.37%、24.76%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223241ab8206e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223241ab8206e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","LENZ","BK4139"],"gpt_icon":0},{"id":"2490012080","title":"Quince Therapeutics, Inc.盘中异动 早盘快速上涨5.39%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490012080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490012080?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:31","pubTimestamp":1733841061,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时31分，Quince Therapeutics, Inc.股票出现波动，股价快速拉升5.39%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Chimerix, Inc.、Uniqure N.V.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为1640.08%、398.07%、84.71%，振幅较大的相关个股有Silexion Therapeutics Corp、Glycomimetics, Inc.、Lantern Pharma Inc.，振幅分别为9.70%、8.97%、6.75%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022310195e8adf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022310195e8adf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","LENZ","BK4139"],"gpt_icon":0},{"id":"2489466354","title":"Quince Therapeutics, Inc.盘中异动 快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489466354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489466354?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:44","pubTimestamp":1733413498,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时44分，Quince Therapeutics, Inc.股票出现异动，股价快速下挫5.00%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Protara Therapeutics, Inc.、Molecular Templates, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Psyence Biomedical Ltd.、Molecular Templates, Inc.、Protara Therapeutics, Inc.较为活跃，换手率分别为2244.15%、1499.46%、389.58%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.、Molecular Templates, Inc.，振幅分别为109.61%、105.08%、100.06%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234458ab6021b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234458ab6021b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","QNCX","BK4139"],"gpt_icon":0},{"id":"2488519751","title":"Quince Therapeutics, Inc.盘中异动 早盘急速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488519751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488519751?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:30","pubTimestamp":1733322647,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时30分，Quince Therapeutics, Inc.股票出现波动，股价急速下挫5.09%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Eterna Therapeutics Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为1166.71%、189.27%、109.36%，振幅较大的相关个股有Theratechnologies Inc.、Organovo Holdings, Inc.、Serina Therapeutics, Inc.，振幅分别为6.79%、5.30%、3.70%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223047a26c5d10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223047a26c5d10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","LENZ","BK4139"],"gpt_icon":0},{"id":"2485065298","title":"Quince Therapeutics, Inc.2024财年第三财季实现净利润-5.49百万美元，同比减少2.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485065298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485065298?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291282,"startTime":"0","endTime":"0","summary":"11月23日，Quince Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-5.49百万美元，同比减少2.62%；其中营业收入为0.00美元，每股基本收益为-0.13美元。机构评级：截至2024年11月23日，当前有3家机构对Quince Therapeutics, Inc.目标价做出预测，其中目标均价为9.67美元，其中最低目标价为6.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000154a24e48e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000154a24e48e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","LENZ"],"gpt_icon":0},{"id":"2484925425","title":"Quince Therapeutics, Inc.盘中异动 急速上涨5.71%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484925425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484925425?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:54","pubTimestamp":1732028074,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时54分，Quince Therapeutics, Inc.股票出现异动，股价急速上涨5.71%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Dermata Therapeutics Inc C/Wts 涨幅较大，Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃，换手率分别为680.61%、90.32%、74.97%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tff Pharmaceuticals, Inc.，振幅分别为81.67%、52.14%、45.03%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922543598e4385b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922543598e4385b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","QNCX"],"gpt_icon":0},{"id":"2484567675","title":"Quince Therapeutics, Inc.盘中异动 急速拉升5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484567675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484567675?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940287,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分，Quince Therapeutics, Inc.股票出现波动，股价大幅上涨5.62%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Hcw Biologics Inc.、冠科美博、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为514.42%、179.03%、175.14%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Innate Pharma、Regenxbio Inc.，振幅分别为11.85%、10.42%、7.48%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822312798e433a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822312798e433a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QNCX","LENZ"],"gpt_icon":0},{"id":"2483855336","title":"Quince Therapeutics, Inc.盘中异动 下午盘股价大跌5.06%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483855336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483855336?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:46","pubTimestamp":1731523605,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时46分，Quince Therapeutics, Inc.股票出现波动，股价大幅跳水5.06%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为539.45%、407.96%、147.63%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为129.00%、73.71%、71.97%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114024645abbe5deb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114024645abbe5deb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QNCX","LENZ"],"gpt_icon":0},{"id":"2481101078","title":"Quince Therapeutics, Inc.盘中异动 股价大涨6.32%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101078?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:41","pubTimestamp":1731076893,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时41分，Quince Therapeutics, Inc.股票出现波动，股价急速上涨6.32%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Matinas Biopharma Holdings, Inc.、Fortrea Holdings Inc.、Poseida Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为435.86%、26.83%、18.15%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Matinas Biopharma Holdings, Inc.、Sab Biotherapeutics, Inc.，振幅分别为86.00%、22.49%、21.41%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224133abae4211&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224133abae4211&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","QNCX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.quincetx.com","stockEarnings":[{"period":"1week","weight":-0.2778},{"period":"1month","weight":-0.9517},{"period":"3month","weight":-0.9274},{"period":"6month","weight":-0.9244},{"period":"1year","weight":-0.9122},{"period":"ytd","weight":-0.9612}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Quince Therapeutics, Inc.于2012年6月20日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，开创了一种新型疾病改善治疗方法，用于治疗被认为是阿尔茨海默氏症和退行性疾病的关键根本原因。该公司的方法是基于在迄今通过多项研究观察到的100多名阿尔茨海默病患者的大脑中，超过90%的人的大脑中发现了牙龈porphyromonas gingivalis或P. gingivalis及其分泌的毒性毒力因子蛋白酶，称为gingipains的开创性发现。此外，该公司在动物模型中观察到牙龈假单胞菌感染会导致阿尔茨海默病理学，这些影响已在临床前研究中成功地用牙龈痛抑制剂治疗。公司专有先导候选药物COR388是一种口服给药、可穿透脑的小分子牙龈痛抑制剂。COR388在迄今为止进行的1a期和1b期临床试验中具有良好的耐受性，没有相关的安全信号，该试验共招募了67名受试者，其中包括9名轻度至中度阿尔茨海默病患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.091321},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.098033},{"month":3,"riseRate":0.5,"avgChangeRate":0.133761},{"month":4,"riseRate":0.5,"avgChangeRate":-0.084014},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.087389},{"month":6,"riseRate":0.714286,"avgChangeRate":0.184618},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.077216},{"month":8,"riseRate":0.428571,"avgChangeRate":0.032954},{"month":9,"riseRate":0.571429,"avgChangeRate":0.013938},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.049658},{"month":11,"riseRate":0.571429,"avgChangeRate":0.199459},{"month":12,"riseRate":0.285714,"avgChangeRate":0.079276}],"exchange":"NASDAQ","name":"Quince Therapeutics, Inc.","nameEN":"Quince Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Quince Therapeutics, Inc.(QNCX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Quince Therapeutics, Inc.(QNCX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Quince Therapeutics, Inc.,QNCX,Quince Therapeutics, Inc.股票,Quince Therapeutics, Inc.股票老虎,Quince Therapeutics, Inc.股票老虎国际,Quince Therapeutics, Inc.行情,Quince Therapeutics, Inc.股票行情,Quince Therapeutics, Inc.股价,Quince Therapeutics, Inc.股市,Quince Therapeutics, Inc.股票价格,Quince Therapeutics, Inc.股票交易,Quince Therapeutics, Inc.股票购买,Quince Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Quince Therapeutics, Inc.(QNCX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Quince Therapeutics, Inc.(QNCX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}